Fund Holdings — Lion Point Capital, LP

Total Portfolio Value:
$19.10M
Total Bought:
$1.86M
Total Sold:
$7.41M
Net Transaction:
-$5.56M
Notable People:
Carl Didric Marcus Cederholm
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Insmed Incorporated(INSM)52,20036,700-15,500$3.81M$2.53M13.27%-$1.28M
Milestone Pharmaceuticals Inc.(MIST)1,654,1541,025,806-628,348$2.51M$2.42M12.68%-$93.4K
Geron Corporation(GERN)630,000500,000-130,000$2.86M$1.77M9.27%-$1.09M
Ardelyx Inc370,000335,400-34,600$2.55M$1.70M8.90%-$848.8K
Fennec Pharmaceuticals Inc.(FENC)215,000195,700-19,300$1.07M$1.24M6.48%+$161.8K
BridgeBio Pharma, Inc.(BBIO)49,00040,300-8,700$1.25M$1.11M5.79%-$141.7K
Mineralys Therapeutics, Inc.(MLYS)79,00079,0000$956.7K$972.5K5.09%+$15.8K
Kiniksa Pharmaceuticals International, plcCL A(KNSA)61,40045,900-15,500$1.53M$907.9K4.75%-$626.5K
Biohaven Ltd.(BHVN)35,40022,700-12,700$1.77M$847.8K4.44%-$921.1K
Benitec Biopharma Inc.(BNTC)39,00062,000+23,000$358.4K$783.1K4.10%+$424.6K
Syndax Pharmaceuticals, Inc.(SNDX)46,20055,000+8,800$889.4K$727.1K3.81%-$162.3K
Jasper Therapeutics, Inc.(JSPR)32,00032,0000$601.9K$684.2K3.58%+$82.2K
Avadel Pharmaceuticals Plc64,00064,0000$839.4K$672.6K3.52%-$166.7K
Disc Medicine, Inc.(IRON)7,70010,600+2,900$378.4K$672.0K3.52%+$293.7K
Bluebird Bio Inc078,912+78,912$0$658.1K3.45%+$658.1K
Arcutis Biotherapeutics, Inc.(ARQT)35,10046,300+11,200$326.4K$645.0K3.38%+$318.5K
REGENXBIO Inc.(RGNX)57,75057,7500$605.8K$446.4K2.34%-$159.4K
Seres Therapeutics, Inc.(MCRB)340,761340,7610$322.4K$283.2K1.48%-$39.2K
Spruce Biosciences Inc75,00075,0000$35.6K$31.5K0.16%-$4.1K
Alphabet Inc.CL C(GOOG)1000-100$16.7K$0—-$16.7K
Bluebird Bio Inc1,578,2560-1,578,256$819.9K$0—-$819.9K
Lumos Pharma Inc39,5890-39,589$153.2K$0—-$153.2K
Marinus Pharmaceuticals Inc693,7780-693,778$1.22M$0—-$1.22M
Microsoft Corporation(MSFT)1000-100$43.0K$0—-$43.0K
Page 1 of 1